Volume 69, Issue 4, Pages 896-904 (October 2018) Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030  Chris Estes, Quentin M. Anstee, Maria Teresa Arias-Loste, Heike Bantel, Stefano Bellentani, Joan Caballeria, Massimo Colombo, Antonio Craxi, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero- Gomez, Arun Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi  Journal of Hepatology  Volume 69, Issue 4, Pages 896-904 (October 2018) DOI: 10.1016/j.jhep.2018.05.036 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2018 69, 896-904DOI: (10. 1016/j. jhep. 2018. 05 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Distribution of NAFLD population by fibrosis stage – 2016 & 2030. NAFLD, non-alcoholic fatty liver disease. Journal of Hepatology 2018 69, 896-904DOI: (10.1016/j.jhep.2018.05.036) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Distribution of NASH population by fibrosis stage – 2015 & 2030. NASH, non-alcoholic steatohepatitis. Journal of Hepatology 2018 69, 896-904DOI: (10.1016/j.jhep.2018.05.036) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Incident decompensated cirrhosis, HCC and liver-related deaths among prevalent NAFLD population – 2015–2030. HCC, hepatocellular carcinoma; NAFLD, non-alcoholic fatty liver disease. Journal of Hepatology 2018 69, 896-904DOI: (10.1016/j.jhep.2018.05.036) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions